Medical Resourcess
Medical Resourcess
Explore cardiology topics, including HF, ASCVD
Explore dermatology topics, including PsO
Explore Oncology topics, including breast cancer
Explore rheumatology topics, including PsA, axSPA
Legal aspects
Lorem ipsum dolor sit amet consectetur. Pharetra ut sit accumsan vulputate senectus. Quam augue felis at tortor purus. Ullamcorper dignissim sed nisi adipiscing morbi gravida. Fringilla nec lacus ornare eu purus amet sem nullam tellus. Molestie.
Medical English
Lorem ipsum dolor sit amet consectetur. Pharetra ut sit accumsan vulputate senectus. Quam augue felis at tortor purus. Ullamcorper dignissim sed nisi adipiscing morbi gravida. Fringilla nec lacus ornare eu purus amet sem nullam tellus. Molestie.
Innovation & digital
Lorem ipsum dolor sit amet consectetur. Pharetra ut sit accumsan vulputate senectus. Quam augue felis at tortor purus. Ullamcorper dignissim sed nisi adipiscing morbi gravida. Fringilla nec lacus ornare eu purus amet sem nullam tellus. Molestie.
Useful links
Lorem ipsum dolor sit amet consectetur. Pharetra ut sit accumsan vulputate senectus. Quam augue felis at tortor purus. Ullamcorper dignissim sed nisi adipiscing morbi gravida. Fringilla nec lacus ornare eu purus amet sem nullam tellus. Molestie.
Upcoming Events - Content Stream Static
[Demo] DAK 2023 - Change of perspective in allergology
[Demo] DAK 2024 - Change of perspective in allergology
[Demo] DAK 2025 - Change of perspective in allergology
[Demo] DAK 2025 - Change of perspective in Haemotology
[Demo] Video on Demand Event
Oncology Seminars - Content Stream Dynamic
Demo of the Video Capability in NVS Pro
Video Content Stream
Novartis
Do you have a question?
Adverse events should be reported.
Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Novartis via [email protected] or online through the pharmacovigilance intake (PVI) tool at www.novartis.com/report. If you have a question about the product, please contact Medical Information on 01276 698370 or by email at [email protected].